AVANOS MEDICAL, INC. (NYSE:AVNS) Shares Sold by Tributary Capital Management LLC

Tributary Capital Management LLC lowered its stake in shares of AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) by 17.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 737,202 shares of the company's stock after selling 155,806 shares during the period. Tributary Capital Management LLC owned 1.60% of AVANOS MEDICAL worth $10,564,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of AVNS. Rice Hall James & Associates LLC grew its holdings in shares of AVANOS MEDICAL by 106.1% in the first quarter. Rice Hall James & Associates LLC now owns 128,059 shares of the company's stock valued at $1,835,000 after purchasing an additional 65,930 shares in the last quarter. Brown Advisory Inc. grew its holdings in shares of AVANOS MEDICAL by 1.4% in the first quarter. Brown Advisory Inc. now owns 1,931,163 shares of the company's stock valued at $27,674,000 after purchasing an additional 26,069 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of AVANOS MEDICAL by 12.6% in the first quarter. Envestnet Asset Management Inc. now owns 144,759 shares of the company's stock valued at $2,074,000 after purchasing an additional 16,192 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of AVANOS MEDICAL by 4.2% in the first quarter. Bank of New York Mellon Corp now owns 329,497 shares of the company's stock valued at $4,722,000 after purchasing an additional 13,258 shares in the last quarter. Finally, Principal Financial Group Inc. grew its holdings in shares of AVANOS MEDICAL by 2.6% in the first quarter. Principal Financial Group Inc. now owns 244,063 shares of the company's stock valued at $3,497,000 after purchasing an additional 6,269 shares in the last quarter. Institutional investors own 95.17% of the company's stock.

AVANOS MEDICAL Trading Down 3.4%

NYSE AVNS traded down $0.39 on Friday, hitting $11.25. 450,766 shares of the stock were exchanged, compared to its average volume of 392,907. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.56 and a current ratio of 2.57. The stock has a fifty day moving average price of $12.32 and a two-hundred day moving average price of $13.84. The firm has a market capitalization of $520.20 million, a P/E ratio of -1.34 and a beta of 1.12. AVANOS MEDICAL, INC. has a 52-week low of $11.21 and a 52-week high of $25.36.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. The firm had revenue of $167.50 million during the quarter, compared to analyst estimates of $161.75 million. AVANOS MEDICAL had a negative net margin of 55.80% and a positive return on equity of 6.26%. The business's revenue was up .8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.22 earnings per share. Research analysts forecast that AVANOS MEDICAL, INC. will post 1.32 EPS for the current fiscal year.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.